| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.8 | 1.0 | 1.0 | 2.2 | 2.9 | 1.4 | −52.8% | |
| Cost of revenue | 1.5 | 1.8 | 2.4 | 13.4 | 11.8 | 9.5 | −20.1% | |
| Gross profit | (0.8) | (0.8) | (1.4) | (11.2) | (9.0) | (8.1) | +9.6% | |
| Research & development | 7.8 | 8.4 | 10.8 | 9.5 | 6.1 | 5.2 | −14.8% | |
| Operating expenses | 12.4 | 16.6 | 23.9 | 8.8 | 6.4 | 6.6 | +2.9% | |
| Operating income | (13.2) | (17.4) | (25.3) | (20.0) | (15.4) | (14.7) | +4.4% | |
| Interest expense | 0.1 | 0.2 | 0.4 | 0.3 | 0.3 | 0.3 | −14.7% | |
| Interest income | 0.1 | 0.0 | 0.1 | 0.5 | 0.4 | 0.1 | −68.2% | |
| Pre-tax income | (13.7) | (17.4) | (24.4) | (21.6) | (15.0) | (20.4) | −35.5% | |
| Income tax | (2.1) | (2.4) | (2.8) | (1.5) | (0.8) | (0.9) | −6.3% | |
| Net income | (11.6) | (15.0) | (21.7) | (20.1) | (14.2) | (19.5) | −37.1% | |
| EPS, basic (per share) | (0.07) | (0.07) | (0.09) | (0.08) | (0.05) | (0.06) | −14.3% | |
| EPS, diluted (per share) | (0.07) | (0.07) | (0.09) | (0.08) | (0.05) | (0.06) | −14.3% | |
| EBITDA | (11.8) | (15.9) | (23.3) | (18.2) | (13.8) | (12.9) | +6.1% | |
| Depreciation & amortization | 1.4 | 1.5 | 2.8 | 1.8 | 1.6 | 1.8 | +9.6% | |
| Weighted average shares (shares) | 178,323,710 | 225,436,986 | 246,977,993 | 260,888,073 | 294,932,245 | 353,834,856 | +20.0% | |
| Weighted average diluted shares (shares) | 178,323,710 | 225,436,986 | 246,977,993 | 260,888,073 | 294,932,245 | 353,834,856 | +20.0% | |
| Gross margin | −100.7% | −74.5% | −133.9% | −513.2% | −313.8% | −600.7% | −286.9 pts | |
| Operating margin | −1,726.6% | −1,714.5% | −2,427.0% | −913.9% | −538.1% | −1,089.6% | −551.6 pts | |
| Net margin | −1,523.1% | −1,481.9% | −2,083.2% | −921.0% | −497.0% | −1,444.0% | −947.0 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
